Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Date Published12/13/2018
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Orchard Therapeutics
Parent companyOrchard Therapeutics
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2018
Year reshoring implemented or to be implemented:2019
Country(ies) from which reshored:United Kingdom
City reshored to:Fremont
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Chemicals, Biopharmaceuticals
Product(s) reshoredgene therapy products
What domestic positive factors made reshoring more attractive?Customization/Flexibility, Higher productivity
Find Reshoring Articles